研修プログラムについて

国立がん研究センター中央病院で肝胆膵外科のスペシャリストに！

診療科としての人材育成のポイント

腫瘍外科医を育てる独自の研修環境の中に

• 消化器外科専門医を目指す一般修練コース
• 肝胆膵外科高度技能専門医を目指す上級修練コースを用意しています。

我々は、ただ専門医の取得を目指すのではなく、どこに行っても「肝胆膵ならこの人」と頼られる、次のことができる“ 真の専門医 ” を育成していきます。

1. 高難度手術において根治性の高い手術を安全にできる。
2. 学会発表・論文作成を行い、後進を指導できる。
3. 正確な診断で手術適応を決め、安全な術後管理を行い、人柄でチームをけん引していくことができる。

国立がん研究センター中央病院肝胆膵外科での研修の特徴

国際学会にも積極的に参加

• 日本の肝胆膵外科をリードする指導医による直接指導
• 毎日の手術症例を通じ、とにかく「見る」⇔「やる」を繰り返す研修
• 臨床研究を中心とした国内外の学術活動のチャンス

全研修コースの載ったPDFはこちら（PDF：1.7MB）です。

充実した研究指導の成果としての多数の英文論文（最近5年間、研修者が first author の論文のみ）

1. Kawakubo N, Esaki M, Nara S, Miyata A, Mizui T, Umino R, Takemoto J, Hishiki T, Yoneda A. Clinical Characteristics of Adolescent and Young Adult Patients Undergoing Pancreatectomy for Malignant Tumors: A 20-Year Single Institution Experience. J Adolesc Young Adult Oncol. 2025 Nov 10. doi: 10.1177/21565333251394590
2. Umino R, Esaki M, Mizui T, Miyata A, Nara S, Hiraoka N. Reappraisal of the Clinical Utility of Hi-Cut Pancreaticoduodenectomy for Widespread Distal Cholangiocarcinoma: A Less Invasive Alternative to Hepatopancreatoduodenectomy. Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18615-9
3. Uotani T, Takamoto T, Nara S, Ban D, Mizui T, Moritani K, Tsukamoto S, Kanemitsu Y, Fujii T, Esaki M. Impact of primary tumor clinicopathological factors on prognosis after hepatic resection for rectal liver metastases. Ann Gastroenterol Surg. 9(4):814-821. 2025
4. Fujinaga A, Takamoto T, Minezaki S, Umino R, Mizui T, Miyata A, Nara S, Esaki M. Delayed Liver Function Recovery After Right Hepatectomy for Metastatic Liver Tumors: Incidence, Risk Factors, and Impact on Prognosis. World J Surg. 49(5):1317-1326. 2025
5. Murase Y, Esaki M, Mizui T, Takamoto T, Nara S, Ban D, Hiraoka N, Shimada K. Optimal lymph node dissection area for pancreatic neuroendocrine neoplasms by tumor location, size, and grade. Surgery. 180:109029. 2025
6. Hirose S, Ban D, Matsui Y, Mizui T, Miyata A, Nara S, Esaki M. Laparoscopic liver resection with retroperitoneoscopy for the treatment of right dorsal liver tumors (with video). Surg Today. 55(5):723-726. 2025
7. Uemura S, Ban D, Esaki M, Nara S, Takamoto T, Mizui T, Shimada K. Risk factor analysis of postoperative pancreatic fistula after distal pancreatectomy with a focus on the peritoneum to portal vein distance on computed tomography. World J Surg. 48(10):2496-2504. 2024
8. Ito S, Takamoto T, Nara S, Ban D, Mizui T, Nagata H, Takamizawa Y, Moritani K, Tsukamoto S, Kanemitsu Y, Kinugasa Y, Esaki M. RAS mutation associated with short surgically controllable period in colorectal liver metastases: a retrospective study. World J Surg Oncol. 12;22(1):247. 2024
9. Umino R, Nara S, Mizui T, Takamoto T, Ban D, Esaki M, Hiraoka N, Shimada K. ASO Author Reflections: Future Perspectives in Surgical Management of Distal Cholangiocarcinoma: Insights from Surgical Margin Status and Recurrence Patterns. Ann Surg Oncol. 1(8):4946-4947. 2024
10. Umino R, Nara S, Mizui T, Takamoto T, Ban D, Esaki M, Hiraoka N, Shimada K. Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence? Ann Surg Oncol. 31(8):4910-4921. 2024
11. Saito R, Ban D, Mizui T, Takamoto T, Nara S, Esaki M, Shimada K. Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. Ann Gastroenterol Surg. 8(3):481-489. 2023
12. Umino R, Nara S, Kobayashi N, Mizui T, Takamoto T, Ban D, Esaki M, Hiraoka N, Shimada K. Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report. Surg Case Rep. 10(1):40. 2024
13. Nagashima D, Esaki M, Nara S, Ban D, Takamoto T, Mizui T, Shimada K, Hiraoka N. Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma. Front Oncol. 13:1216097. 2023
14. Kitamura K, Esaki M, Sone M, Sugawara S, Hiraoka N, Nara S, Ban D, Takamoto T, Mizui T, Shimada K. ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. Ann Surg Oncol. 29(11):7059-7060. 2022
15. Kitamura K, Esaki M, Sone M, Sugawara S, Hiraoka N, Nara S, Ban D, Takamoto T, Mizui T, Shimada K. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. Ann Surg Oncol. 29(11):7047-7058. 2022
16. Okura K, Esaki M, Nara S, Ban D, Takamoto T, Shimada K, Hiraoka N. Hepatoid carcinoma and related entities of the extrahepatic bile duct: A clinicopathological study of four cases. Pathol Int. 332-342. 2022
17. Yamada S, Kishi Y, Miyake M, Nara S, Esaki M, Shimada K. Characteristics of false-positive lesions in evaluating colorectal liver metastases on gadoxetic acid-enhanced magnetic resonance imaging. Surg Today. 1178-1184. 2022
18. Iwasaki T, Nara S, Nishimura Y, Ueda H, Kishi Y, Esaki M, Shimada K, Hiraoka N. Postoperative acute multiple organ failure after hepatectomy in a Nigerian male with sickle cell trait: a case report. Surg Case Rep. 13;7(1):19. 2021
19. Ishida T, Nara S, Akahoshi K, Takamoto T, Kishi Y, Esaki M, Hiraoka N, Shimada K. Left hepatic trisectionectomy for perihilar cholangiocarcinoma with a right-sided round ligament: A case report. World J Gastrointest Surg. 12(2): 68-76. 2020
20. Asano D, Nara S, Kishi Y, Esaki M, Hiraoka N, Tanabe M, Shimada K. A Single-Institution Validation Study of Lymph Node Staging By the AJCC 8th Edition for Patitnets with Pancreatic Head Cancer: A Proposal to Sugdivide the N2 Category. Ann Surg Oncol. 26(7): 2112-2120. 2019

研修に関するお問合せ先

• 国立がん研究センター 中央病院 肝胆膵外科
  教育担当：水井 崇浩
  メールアドレス：tmizui●ncc.go.jp
• 中央病院レジデント募集情報
  https://www.ncc.go.jp/jp/cepcd/recruit/20220823090229.html
  
• Facebook 中央病院 教育・研修情報
  https://ja-jp.facebook.com/CancerEducation/（外部サイトへリンクします）